Metallothionein overexpression in human brain tumours

Acta Neuropathologica

Volumn 94, Issue 6, 1997, Pages 599-604

  Maier, Hans ^a,b   Jones, Chris ^c   Jasani, Bharat ^c   Öfner, Dietmar ^b   Zelger, Bettina ^b   Schmid, Kurt Werner ^d   Budka, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Gliomas; Immunohistochemistry; Meningiomas; Metallothioneins

Indexed keywords

CYTOTOXIC AGENT; METALLOTHIONEIN;

ARTICLE; BRAIN TUMOR; DRUG RESISTANCE; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ADULT; AGED; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM STAGING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030813197     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050755     Document Type: Article

References (46)

1. Andrews PA, Murphy MP, Howell SB (1987) Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 19: 149-154
2. Bankfalvi A, Navabi H, Bier B, Böcker W, Schmid KW (1994) Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 174: 223-228
3. Cavallo F, Gerter M, Marubini E, Richardson S, Barbieri A, Costa A, DeCarli A, Pujol H (1991) Zinc and copper in breast cancer. A joint study in northern Italy and southern France. Cancer 67: 738-745
4. Cherian MG, Goyer RA (1978) Metallothioneins and their role in the metabolism and toxicity of metals. Life Sci 23: 1-8
5. Cherian MG, Huang PC, Klaasen CD, Lin Y-P, Lonfellow DG, Waalkes MP (1993) National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 53: 922-925
6. Chin JL, Banerjee D, Kadhim SA, Kontozoglu TE, Chauvin PJ, Cherian MG (1993) Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation. Cancer 72: 3029-3035
7. Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
8. Coffer AI, Knowles PP (1994) Divalent metal ions induce conformational change in pure, human wild-type p53 tumor suppressor gene. Biochim Biophys Acta 1209: 279-285
9. Cousins RJ (1983) Metallothionein - aspects related to copper and zinc metabolism. J Inherit Metab Dis 6: 15-21
10. Ebadi M, Iversen PL (1994) Metallothionein in carcinogenesis and cancer chemotherapy. Gen Pharmacol 25: 1297-1310
11. Elmes ME, Clarkson JP, Mahy NJ, Jasani B (1989) Metallothionein and copper in liver disease with copper retention - a histopathological study. J Pathol 158: 131-137
12. Evering WE, Haywood S, Elmes ME, Jasani B, Trafford J (1990) Histochemical evaluation of copper and metallothionein in the liver and kidney of copper-loaded rats. J Pathol 160: 305-312
13. Fresno M, Wu R, Rodriguez JM, Nadji M (1993) Localization of metallothionein in breast carcinoma. An immunohistological study. Virchows Arch [A] 423: 215-219
14. Fuller CE, Elmes ME, Jasani B (1990) Age-related changes in metallothionein, copper, copper-associated protein, and lipofuscin in human liver: a histochemical and immunohistochemical study. J Pathol 161: 167-172
15. Haerslev T, Jakobsen K, Nedergaard L, Zedeler K (1994) Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Pathol Res Pract 190: 675-681
16. Hainaut P, Milner JA (1993) A structural role for metal ions in the "wild-type" conformation of the tumour suppressor protein p53. Cancer Res 53: 1739-1742
17. Jasani B, Elmes ME (1991) Immunohistochemical detection of metallothionein. Methods Enzymol 205: 95-107
18. Kägi JHR (1991) Overview of metallothionein. Methods Enzymol 205: 613-626
19. Kägi JHR, Nordberg M (1979) Metallothionein. Birkhäuser, Basel
20. Kägi JHR, Himmelhoch SR, Whanger PD, Bethune JL, Vallee BL (1974) Equine hepatic and renal metallothioneins: purification, molecular weight, amino acid composition, and metal content. J Biol Chem 249: 3537-3542
21. Kelley SM, Basu A, Teicher BA, Hacher MP, Hamer DH, Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815
22. Kepes JJ (1982) Meningiomas. Biology, pathology, and differential diagnosis. Masson, New York
23. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York
24. Koizumi S, Suzuki K, Otsuka F (1992) A nuclear factor that recognizes the metal-responsive elements of human metallothionein IIA gene. J Biol Chem 267: 18659-18664
25. Kondo Y, Satoh M, Imura N, Akimoto M (1992) Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamrninedichloroplatinum (II) against bladder tumor. Anticancer Res 12: 2303-2307
26. Ludwin SK, Rubinstein LJ, Russell DS (1975) Papillary meningioma: a malignant variant of meningioma. Cancer 36: 1363-1373
27. Maier H, Öfner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg. 77: 616-623
28. Nath R, Kambadur R, Gulati S, Paliwal VK, Sharma M (1986) Molecular aspects, physiological functions, and clinical significance of metallothioneins. Crit Rev Food Sci Nutr 55: 41-85
29. Neal JW, Singhrao SK, Jasani B, Newman GR (1996) Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain. Neuropathol Appl Neurobiol 22: 243-247
30. Öfner D, Maier H, Riedmann B, Bammer T, Rumer A, Winde G, Böcker W, Jasani B, Schmid KW (1994) Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch 425: 491-497
31. Osmak M (1993) Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine. Neoplasma 40: 97-101
32. Pasquier B, Gasnier F, Pasquier D, Keddari E, Morens A, Couderc P (1986) Papillary meningioma. Clinicopathologic study of seven cases and review of the literature. Cancer 58: 299-305
33. Pavletich NP, Chambers KA, Pabo CO (1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7: 2556-2564
34. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, Mann K (1995) Role of cysteine residues in regulation of p53 function. Mol Cell Biol 15: 3892-3903
35. Riordan JR, Richards V (1980) Human fetal liver contains both zinc and copper-rich forms of metallothionein. J Biol Chem 255: 5380-5384
36. Satoh M, Kloth DM, Kadhim SA, Chin JL, Naganuma A, Imura N, Cherian MG (1993) Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 53: 1829-1832
37. Schmid KW, Ellis IO, Gee JMW, Darke BM, Lees WE, Kay J, Cryer A, Stark A, Hittmair A, Öfner D, Dünser M, Margreiter R, Daxenbichler G, Nicholson RI, Bier B, Böcker W, Jasani B (1993) Presence and possible significance of immunocyto-chemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch [A] 422: 153-159
38. Schmid KW, Greeff M, Hittmair A, Tötsch M, Öfner D, Dockhorn-Dworniczak B, Böcker W, Jasani B (1994) Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular cells using monoclonal antimetallothionein antibody E9. Endocr Pathol 5: 114-122
39. Schmidt CJ, Hamer DH (1986) Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci USA 83: 3346-3350
40. Stratton MR, Collins N, Lakhani SR, Sloane JP (1995) Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175: 195-201
41. Suzuki K, Nakajima K, Kawaharada U, Uehara K, Hara F, Otaki N, Kimura M, Tamura Y (1992) Metallothionein in the human brain. Acta Histochem Cytochem 25: 617-622
42. Suzuki K, Nakajima K, Otaki N, Kimura M, Kawaharada U, Katsuyoshi U, Hara F, Nakazato Y, Takatama M (1994) Localization of metallothionein in aged human brain. Pathol Int 44: 20-26
43. Thornalley PJ, Vasak M (1985) Possible role of metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with Superoxide and hydroxyl radicals. Biochim Biophys Acta 827: 36-44
44. Webber MM, Rehman SMM, James GT (1988) Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin. Cancer Res 48: 4503-4508
45. Wilkinson L (1989) SYSTAT: the system of statistics. Systat, Evanston
46. Zeiger B, Hittmair A, Schir M, Öfner C, Öfner D, Fritsch PO, Böcker W, Jasani B, Schmid KW (1993) Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 23: 257-264